Patents by Inventor Gary HENDLER

Gary HENDLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ERIBULIN AND CYCLIN DEPENDENT KINASE INHIBITORS IN THE TREATMENT OF CANCER
    Publication number: 20200129473
    Abstract: The invention features methods for treating and preventing cancer (e.g., an estrogen receptor-positive (ER+) breast cancer) in a patient in need thereof by administering eribulin (e.g., eribulin mesylate) in combination with a cyclin dependent kinase (CDK) inhibitor.
    Type: Application
    Filed: July 23, 2018
    Publication date: April 30, 2020
    Inventors: Bruce A. LITTLEFIELD, Gary HENDLER
  • USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER
    Publication number: 20190282541
    Abstract: The invention features methods for treating and preventing cancer (e.g., a hormone sensitive cancer) in a patient in need thereof by administering eribulin (e.g., eribulin mesylate) in combination with a histone deacetylase (HDAC) inhibitor.
    Type: Application
    Filed: July 20, 2017
    Publication date: September 19, 2019
    Inventors: Bruce A. LITTLEFIELD, Gary HENDLER